Gayatri Sathyan
Keine laufenden Positionen mehr
Profil
Gayatri Sathyan worked as a Senior Director at ALZA Corp.
and as a Vice President-Clinical Pharmacology at Adamas Pharmaceuticals LLC.
She holds a graduate and doctorate degree from the University of Cincinnati (Ohio).
Ehemalige bekannte Positionen von Gayatri Sathyan
| Unternehmen | Position | Ende |
|---|---|---|
| ALZA CORPORATION | Direktor/Vorstandsmitglied | - |
| ADAMAS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Ausbildung von Gayatri Sathyan
| University of Cincinnati (Ohio) | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA. | Health Technology |
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
